| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.028 | 0.8 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |